Clinical trials in Italy

Clinical trials on stem cells involving Italian Research Groups

(221 studies updated February 20, 2013)


1 Recruiting Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: Human Neural Stem Cells
2 Completed
Has Results
Respiratory Impedance and Obliterative Bronchiolitis
Conditions: Hematopoietic Stem Cell Transplantation;   Obliterative Bronchiolitis
Intervention: Drug: albuterol
3 Recruiting Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide After Hematopoietic Stem-cell Transplantation
Condition: Lung Disease
4 Unknown  Hematopoietic Stem Cell Transplantation in Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: Hematopoietic Stem Cell Transplantation
5 Completed A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia
Condition: Acute Myelogenous Leukemia
Intervention: Behavioral: Two-step remission induction and risk-oriented consolidation
6 Recruiting A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)
Condition: Acute Myelogenous Leukemia
Intervention: Drug: cytosine arabinoside
7 Active, not recruiting Dose-reduced Versus Standard Conditioning in MDS/sAML
Conditions: Myelodysplastic Syndromes;   Secondary Acute Myeloid Leukemia
Interventions: Other: Reduced Intensity Conditioning;   Other: Myeloablative conditioning
8 Completed Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Condition: Cancer
Intervention: Drug: caspofungin acetate
9 Recruiting Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients
Conditions: Myelodysplastic Syndrome;   Secondary Acute Myeloid Leukemia
Interventions: Procedure: Standard conditioning prior allo SCT;   Procedure: Dose-reduced conditioning prior allo SCT
10 Recruiting Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
Condition: Central Nervous System Lymphoma
Interventions: Drug: Methotrexate;   Drug: Ara-C;   Drug: Rituximab;   Drug: Thiotepa;   Radiation: radiotherapy;   Drug: BCNU;   Other: APBSCT
11 Completed
Has Results
Bronchodilator Responsiveness in Obliterative Bronchiolitis
Condition: Obliterative Bronchiolitis
Intervention: Drug: albuterol plus tiotropium
12 Completed Treatment of Adult ALL With an MRD-directed Programme.
Condition: Acute Lymphoblastic Leukemia
Intervention: Behavioral: Postremission consolidation based on MRD status
13 Terminated Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor
Conditions: Myeloid Leukemia;   Lymphoblastic Leukemia;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndrome;   Myeloproliferative Disorders
Intervention: Biological: Donor lymphocyte preparation depleted of host functional alloreactive T-cells
14 Completed Effect of Sitagliptin on Endothelial Progenitor Cells
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin
15 Recruiting Gene Therapy for Wiskott-Aldrich Syndrome
Condition: Wiskott-Aldrich Syndrome
Intervention: Genetic: Autologous CD34 positive cells transduced with WAS encoding lentiviral vector.
16 Recruiting Bone Marrow Progenitor Cell Mobilization in Diabetes
Condition: Diabetes Mellitus
Intervention: Drug: Filgrastim, hrG-CSF
17 Recruiting High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
18 Completed Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
Condition: Critical Limb Ischemia
Intervention: Other: Endothelial progenitor cells intramuscular implant
19 Unknown  Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)
Condition: Multiple Myeloma
Intervention: Procedure: Hematopoietic Stem Cell Transplantation
20 Unknown  Diabetic Foot and Vascular Progenitor Cells
Conditions: Diabetes;   Chronic Critical Ischemia
Within a number of situations, you might possibly know the actual design as well as kind of cartier replica uk that the designed individual requirements. They can be a specific enthusiast of the custom, or even they may possess esteemed the actual tag heuer replica uk of the unique look at previously. However, you might possibly possess just the fundamental describe from the kind they would like, regardless of fake rolex it's a precious metal or even metallic 1, or even possibly a little having a leather-based secure, pretty compared to plastic material. Probably the most typical conditions many people encounter although breitling replica uk on the internet is actually purchasing phony items. You will find numerous scammers on the web that market phony items to be able to dupe individuals as well as grab their own cash.